title: Histone deacetylase inhibitors reduce steroidogenesis through SCF-mediated ubiquitination and degradation of steroidogenic factor 1 (NR5A1).
abstract: Histone deacetylase (HDAC) inhibitors such as trichostatin A and valproic acid modulate transcription of many genes by inhibiting the activities of HDACs, resulting in the remodeling of chromatin. Yet this effect is not universal for all genes. Here we show that HDAC inhibitors suppressed the expression of steroidogenic gene CYP11A1 and decreased steroid secretion by increasing the ubiquitination and degradation of SF-1, a factor important for the transcription of all steroidogenic genes. This was accompanied by increased expression of Ube2D1 and SKP1A, an E2 ubiquitin conjugase and a subunit of the E3 ubiquitin ligase in the Skp1/Cul1/F-box protein (SCF) family, respectively. Reducing SKP1A expression with small interfering RNA resulted in recovery of SF-1 levels, demonstrating that the activity of SCF E3 ubiquitin ligase is required for the SF-1 degradation induced by HDAC inhibitors. Overexpression of exogenous SF-1 restored steroidogenic activities even in the presence of HDAC inhibitors. Thus, increased SF-1 degradation is the cause of the reduction in steroidogenesis caused by HDAC inhibitors. The increased SKP1A expression and SCF-mediated protein degradation could be the mechanism underlying the mode of action of HDAC inhibitors.
authors: Institute of Molecular Biology, Academia Sinica, Nankang, Taipei, Taiwan.
authors: Wei-Yi
authors: WY
authors: Chen
authors: Jui-Hsia
authors: JH
authors: Weng
authors: Chen-Che
authors: CC
authors: Huang
authors: Bon-Chu
authors: BC
authors: Chung
mesh_terms: D000302:Adrenal Cortex / Q000166:cytology; D000818:Animals; D002460:Cell Line; D002786:Cholesterol Side-Chain Cleavage Enzyme / Q000235:genetics / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000378:metabolism; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000378:metabolism; D006801:Humans; D006877:Hydroxamic Acids / Q000378:metabolism; D051379:Mice; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D034622:RNA Interference; D044843:SKP Cullin F-Box Protein Ligases / Q000235:genetics / Q000378:metabolism*; D054339:Steroidogenic Factor 1 / Q000235:genetics / Q000378:metabolism*; D013256:Steroids / Q000096:biosynthesis*; D025801:Ubiquitin / Q000378:metabolism*; D014635:Valproic Acid / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D054339:Steroidogenic Factor 1; D013256:Steroids; D025801:Ubiquitin; C012589:trichostatin A; D014635:Valproic Acid; D002786:Cholesterol Side-Chain Cleavage Enzyme; D044843:SKP Cullin F-Box Protein Ligases; D046988:Proteasome Endopeptidase Complex; D006655:Histone Deacetylases
references: Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1032-7
references: 10655479
references: Mol Endocrinol. 1990 Jun;4(6):893-8
references: 2233746
references: Biochem J. 1991 Mar 15;274 ( Pt 3):813-7
references: 1849407
references: J Biol Chem. 1992 Sep 5;267(25):17913-9
references: 1517227
references: Mol Endocrinol. 1992 Aug;6(8):1249-58
references: 1406703
references: Steroids. 1995 Jan;60(1):10-4
references: 7792792
references: Mol Endocrinol. 1995 Oct;9(10):1346-55
references: 8544843
references: Mol Endocrinol. 1997 Feb;11(2):117-26
references: 9013759
references: J Biol Chem. 1997 Apr 4;272(14):9287-93
references: 9083064
references: Proc Natl Acad Sci U S A. 1997 May 27;94(11):5798-803
references: 9159154
references: Endocr Rev. 1997 Jun;18(3):361-77
references: 9183568
references: J Biol Chem. 1998 Feb 20;273(8):4585-91
references: 9468515
references: Mol Cell. 1999 Apr;3(4):521-6
references: 10230405
references: Nat Genet. 1999 Jun;22(2):125-6
references: 10369247
references: Clin Cancer Res. 2004 Dec 1;10(23):8094-104
references: 15585645
references: Mol Cell Biol. 2005 Jan;25(2):525-32
references: 15632055
references: Cell. 2005 Feb 11;120(3):343-55
references: 15707893
references: Mol Cell Biol. 2005 Mar;25(5):1879-90
references: 15713642
references: Mol Cell. 2005 Feb 18;17(4):491-502
references: 15721253
references: Cancer Res. 2005 Apr 1;65(7):2684-9
references: 15805266
references: Oncogene. 2005 Apr 18;24(17):2860-70
references: 15838520
references: Semin Cell Dev Biol. 2005 Jun;16(3):323-33
references: 15840441
references: Proc Natl Acad Sci U S A. 2005 May 24;102(21):7505-10
references: 15897460
references: Mol Cell Biol. 2005 Dec;25(23):10442-53
references: 16287857
references: Nat Rev Cancer. 2006 May;6(5):369-81
references: 16633365
references: Nat Rev Drug Discov. 2006 Sep;5(9):769-84
references: 16955068
references: Mol Cell Biol. 2007 Mar;27(6):2027-36
references: 17210646
references: Cell Cycle. 2005 Jun;4(6):741-3
references: 15908787
references: Am J Hum Genet. 2000 Dec;67(6):1563-8
references: 11038323
references: Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14488-93
references: 11121051
references: Genome Biol. 2000;1(5):REVIEWS3002
references: 11178263
references: J Biol Chem. 2001 Oct 5;276(40):37659-64
references: 11479297
references: Annu Rev Biochem. 2001;70:503-33
references: 11395416
references: Mol Cell Biol. 2002 Oct;22(20):7193-203
references: 12242296
references: EMBO J. 2003 Jul 1;22(13):3411-20
references: 12840003
references: CNS Drug Rev. 2003 Summer;9(2):199-216
references: 12847559
references: Neurology. 2004 Feb 10;62(3):445-50
references: 14872028
references: Mol Endocrinol. 2004 Mar;18(3):493-9
references: 14673136
references: J Biol Chem. 2004 Mar 26;279(13):12020-6
references: 14702340
references: Mol Endocrinol. 2004 Apr;18(4):941-52
references: 14726490
references: J Biol Chem. 2004 Sep 10;279(37):38730-5
references: 15192092
references: Mol Endocrinol. 2004 Oct;18(10):2451-62
references: 15192080
references: Endocrinology. 1988 Apr;122(4):1532-40
references: 3345726
references: Seizure. 2000 Oct;9(7):480-5
references: 11034872